Novartis Investigative Site

Saga, Saga-ken 849-8501

0 studies enrolling now · 4 studies all time

What they study most

Chronic Heart Failure, Chronic Myelogenous Leukemia, Non Alcoholic Steatohepatitis (NASH), Non-alcoholic Steatohepatitis (NASH)

Studies at this site

• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. — Stopped early
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed